GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osel Devices Ltd (NSE:OSELDEVICE) » Definitions » ROE %

Osel Devices (NSE:OSELDEVICE) ROE % : 69.37% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Osel Devices ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Osel Devices's annualized net income for the quarter that ended in Mar. 2024 was ₹131 Mil. Osel Devices's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was ₹188 Mil. Therefore, Osel Devices's annualized ROE % for the quarter that ended in Mar. 2024 was 69.37%.

The historical rank and industry rank for Osel Devices's ROE % or its related term are showing as below:

NSE:OSELDEVICE' s ROE % Range Over the Past 10 Years
Min: 27.16   Med: 40.2   Max: 69.37
Current: 69.37

During the past 4 years, Osel Devices's highest ROE % was 69.37%. The lowest was 27.16%. And the median was 40.20%.

NSE:OSELDEVICE's ROE % is ranked better than
99.38% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 0.94 vs NSE:OSELDEVICE: 69.37

Osel Devices ROE % Historical Data

The historical data trend for Osel Devices's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osel Devices ROE % Chart

Osel Devices Annual Data
Trend Mar21 Mar22 Mar23 Mar24
ROE %
27.16 33.60 46.79 69.37

Osel Devices Semi-Annual Data
Mar21 Mar22 Mar23 Mar24
ROE % 27.16 33.60 46.79 69.37

Competitive Comparison of Osel Devices's ROE %

For the Medical Devices subindustry, Osel Devices's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Osel Devices's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osel Devices's ROE % distribution charts can be found below:

* The bar in red indicates where Osel Devices's ROE % falls into.



Osel Devices ROE % Calculation

Osel Devices's annualized ROE % for the fiscal year that ended in Mar. 2024 is calculated as

ROE %=Net Income (A: Mar. 2024 )/( (Total Stockholders Equity (A: Mar. 2023 )+Total Stockholders Equity (A: Mar. 2024 ))/ count )
=130.521/( (122.9+253.421)/ 2 )
=130.521/188.1605
=69.37 %

Osel Devices's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=130.521/( (122.9+253.421)/ 2 )
=130.521/188.1605
=69.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Osel Devices  (NSE:OSELDEVICE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=130.521/188.1605
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(130.521 / 1322.335)*(1322.335 / 738.3145)*(738.3145 / 188.1605)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.87 %*1.791*3.9239
=ROA %*Equity Multiplier
=17.68 %*3.9239
=69.37 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=130.521/188.1605
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (130.521 / 185.456) * (185.456 / 219.216) * (219.216 / 1322.335) * (1322.335 / 738.3145) * (738.3145 / 188.1605)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7038 * 0.846 * 16.58 % * 1.791 * 3.9239
=69.37 %

Note: The net income data used here is one times the annual (Mar. 2024) net income data. The Revenue data used here is one times the annual (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Osel Devices ROE % Related Terms

Thank you for viewing the detailed overview of Osel Devices's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Osel Devices Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 3, Sector Knowledge Park- III, Signature Tower First Floor, Sector 34, Gautam Buddha Nagar, Greater Noida, UP, IND, 201308
Website
Osel Devcies Ltd manufactures a comprehensive range of LED display systems and hearing aids. The company manufactures a comprehensive range of LED display systems including all major components for commercial use such as advertising media, billboards, corporate boardrooms, presentations, display promotions, command centers, and front signs. It also manufactures hearing aids, commonly known as health aids, to assist people with disabilities, the elderly, and the chronically ill who have low hearing levels. The company's main customer for hearing aids is the Artificial Limbs Manufacturing Corporation of India. Osel Devcies Generates the majority of revenue from Hearing Aids.

Osel Devices Headlines

No Headlines